Sorrento Therapeutics, Inc. SRNE
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.009 Day range 0.01
0.0001 52-week range 0.015
- YTD
- -88.46%
- 1 year
- -96.05%
- Open
- 0.009
- Prev close
- 0.0003
- Mkt cap
- 165.38K
- Vol
- 501.68K
- Avg vol
- 80.38K
- EPS
- -0.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.009
- High
- 0.01
- Forward P/E
- -0.45
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 4, 2024
- 50-d avg
- 0.817524
- 200-d avg
- 1.58
- 1y target
- 13.00
3M chart
Signals (24)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
Newest 20 of 24.
Analyst view
Consensus: buy
Buy
Price target (mean) 13.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.19 | -0.23 – -0.15 | -0.40 | +52.5% | 18.22M | +39.3% | 2 |
| Next quarter | -0.16 | -0.16 – -0.16 | -0.47 | +66.0% | 20.00M | +8.8% | 1 |
| Current year | -1.05 | -1.09 – -1.01 | -1.45 | +27.6% | 65.45M | +23.7% | 2 |
| Next year | -0.68 | -0.80 – -0.56 | -1.05 | +35.2% | 57.53M | -12.1% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 25, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 9, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jan 21, 2021 | Alliance Global Partners | Initiated | — | Buy |
| Jul 31, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| May 26, 2020 | Dawson James | Initiated | — | Buy |
| Mar 30, 2020 | H.C. Wainwright | Reiterated | — | Buy |
| Oct 7, 2019 | JMP Securities | Initiated | — | Market Outperform |
| Mar 20, 2019 | B. Riley FBR | Maintained | Buy | Buy |
| Jun 28, 2018 | B. Riley FBR | Initiated | — | Buy |
| Apr 3, 2018 | H.C. Wainwright | Maintained | Buy | Buy |
| Nov 15, 2017 | Oppenheimer | Maintained | — | Outperform |
| Aug 4, 2017 | Oppenheimer | Initiated | — | Outperform |
| Oct 3, 2016 | Roth Capital | Initiated | — | Buy |
| Apr 5, 2016 | Rodman & Renshaw | Maintained | — | Buy |
| Feb 29, 2016 | Rodman & Renshaw | Maintained | — | Buy |
| Dec 22, 2015 | FBR Capital | Initiated | — | Outperform |
| Nov 25, 2015 | Brean Capital | Maintained | — | Buy |
| May 28, 2015 | Brean Capital | Initiated | — | Buy |